BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38264227)

  • 1. Exploring mechanisms underlying diabetes comorbidities and strategies to prevent vascular complications.
    Sasako T
    Diabetol Int; 2024 Jan; 15(1):34-40. PubMed ID: 38264227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring mechanisms of insulin action and strategies to treat diabetes.
    Sasako T
    Endocr J; 2024 May; ():. PubMed ID: 38811207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia: Loss of mighty armor against frailty and aging.
    Sasako T; Ueki K
    J Diabetes Investig; 2023 Oct; 14(10):1145-1147. PubMed ID: 37551792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.
    Aljaylani A; Fluitt M; Piselli A; Shepard BD; Tiwari S; Ecelbarger CM
    Cell Physiol Biochem; 2020 Jul; 54(4):682-695. PubMed ID: 32678535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CYP4A reduces hepatic endoplasmic reticulum stress and features of diabetes in mice.
    Park EC; Kim SI; Hong Y; Hwang JW; Cho GS; Cha HN; Han JK; Yun CH; Park SY; Jang IS; Lee ZW; Choi JS; Kim S; Kim GH
    Gastroenterology; 2014 Oct; 147(4):860-9. PubMed ID: 24983671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
    ; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
    J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential effect of Montelukast on Dapagliflozin: Modulation of IRS-1/AKT/GLUT4 and ER stress response elements improves insulin sensitivity in soleus muscle of a type-2 diabetic rat model.
    Fleifel AM; Soubh AA; Abdallah DM; Ahmed KA; El-Abhar HS
    Life Sci; 2022 Oct; 307():120865. PubMed ID: 35934057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of reduced insulin-stimulated bone blood flow in the pathogenesis of metabolic insulin resistance and diabetic bone fragility.
    Hinton PS
    Med Hypotheses; 2016 Aug; 93():81-6. PubMed ID: 27372862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.
    Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M
    Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions.
    Swe MT; Pongchaidecha A; Chatsudthipong V; Chattipakorn N; Lungkaphin A
    J Cell Physiol; 2019 Jun; 234(6):8134-8151. PubMed ID: 30370538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the endoplasmic reticulum subproteome in the livers of type 2 diabetic mice.
    Park EC; Kim GH; Yun SH; Lim HL; Hong Y; Kwon SO; Kwon J; Chung YH; Kim SI
    Int J Mol Sci; 2012 Dec; 13(12):17230-43. PubMed ID: 23247284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
    Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
    Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
    Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
    Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle.
    Hwang SL; Jeong YT; Li X; Kim YD; Lu Y; Chang YC; Lee IK; Chang HW
    Br J Pharmacol; 2013 May; 169(1):69-81. PubMed ID: 23373714
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.